158 related articles for article (PubMed ID: 30430627)
1. Combination therapy of sirolimus and acitretin in solid organ transplant recipients: a new cutaneous adverse event.
Skillen LA; Corry A
Clin Exp Dermatol; 2019 Jan; 44(1):62-63. PubMed ID: 30430627
[No Abstract] [Full Text] [Related]
2. Serum Sirolimus Level Elevation Induced by Acitretin: Report of a Novel Drug-Drug Interaction.
Rossi AM; Hibler BP; Johnson-Jahangir H
J Drugs Dermatol; 2015 Jul; 14(7):747-9. PubMed ID: 26151793
[TBL] [Abstract][Full Text] [Related]
3. The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
Leblanc KG; Hughes MP; Sheehan DJ
Dermatol Surg; 2011 Jun; 37(6):744-9. PubMed ID: 21605234
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment.
Kim C; Cheng J; Colegio OR
Semin Oncol; 2016 Jun; 43(3):390-4. PubMed ID: 27178693
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose Acitretin for Secondary Prevention of Keratinocyte Carcinomas in Solid-Organ Transplant Recipients.
Solomon-Cohen E; Reiss-Huss S; Hodak E; Davidovici B
Dermatology; 2022; 238(1):161-166. PubMed ID: 33902035
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus and secondary skin-cancer prevention in kidney transplantation.
Euvrard S; Morelon E; Rostaing L; Goffin E; Brocard A; Tromme I; Broeders N; del Marmol V; Chatelet V; Dompmartin A; Kessler M; Serra AL; Hofbauer GF; Pouteil-Noble C; Campistol JM; Kanitakis J; Roux AS; Decullier E; Dantal J;
N Engl J Med; 2012 Jul; 367(4):329-39. PubMed ID: 22830463
[TBL] [Abstract][Full Text] [Related]
7. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
[TBL] [Abstract][Full Text] [Related]
8. Effect of acitretin on wound healing in organ transplant recipients.
Tan SR; Tope WD
Dermatol Surg; 2004 Apr; 30(4 Pt 2):667-73. PubMed ID: 15061853
[TBL] [Abstract][Full Text] [Related]
9. Use of sirolimus in solid organ transplantation.
Augustine JJ; Bodziak KA; Hricik DE
Drugs; 2007; 67(3):369-91. PubMed ID: 17335296
[TBL] [Abstract][Full Text] [Related]
10. Isolated sixth nerve palsy during acitretin treatment: a retinoid side effect or a mere coincidence?
Chroni E; Tsambaos D
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1024-5; author reply 1025. PubMed ID: 18540983
[No Abstract] [Full Text] [Related]
11. Immunohistochemical effects of temporary cessation of long-term acitretin treatment in keratinocytic intraepidermal neoplasia of renal transplant recipients.
Blokx WA; Smit JV; de Wilde PC; van de Kerkhof PC; Ruiter DJ; de Jong EM
Arch Dermatol; 2003 May; 139(5):671-3. PubMed ID: 12756113
[No Abstract] [Full Text] [Related]
12. Acitretin-Altered Squamous Cell Carcinoma: A Pitfall in Diagnosis.
Koh WL; Oon HH; Tan WP
Dermatol Surg; 2019 Feb; 45(2):311-313. PubMed ID: 29781905
[No Abstract] [Full Text] [Related]
13. Comment on "Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)".
Longo MI; Wen X; Womer KL
J Am Acad Dermatol; 2016 May; 74(5):e105-6. PubMed ID: 27085243
[No Abstract] [Full Text] [Related]
14. Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.
Herold M; Good AJ; Nielson CB; Longo MI
Dermatol Surg; 2019 Dec; 45(12):1442-1449. PubMed ID: 31403546
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
Tee LY; Sultana R; Tam SYC; Oh CC
J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631
[No Abstract] [Full Text] [Related]
16. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
[TBL] [Abstract][Full Text] [Related]
17. Early and Severe Radiation Toxicity Associated with Concurrent Sirolimus in an Organ Transplant Recipient with Head and Neck Cutaneous Squamous Cell Carcinoma: A Case Report.
Manyam BV; Nwizu TI; Rahe ML; Harr BA; Koyfman SA
Anticancer Res; 2015 Oct; 35(10):5511-4. PubMed ID: 26408717
[TBL] [Abstract][Full Text] [Related]
18. Multiple cutaneous squamous carcinoma in a psoriatic associated with ciclosporin, alcohol abuse and ultraviolet radiation exposure which were suppressed by acitretin.
Agnew KL; Bunker CB
J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):113-4. PubMed ID: 12602995
[No Abstract] [Full Text] [Related]
19. Acitretin: no pregnancy during treatment and, as a precaution, for 3 years after discontinuation.
Prescrire Int; 2013 Sep; 22(141):213. PubMed ID: 24171216
[No Abstract] [Full Text] [Related]
20. An unusual cutaneous-polyposis syndrome stabilized with acitretin.
Schmulewitz L; Attard N; Fearfield L; Westaby D; Prasad P; Thomas HJ; Bunker CB
Br J Dermatol; 2008 Jul; 159(1):228-30. PubMed ID: 18503591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
